Source abstract
Abstract
In vitro engineering of salivary glands relies on the availability of synthetic matrices presenting essential cell-instructive signals to guide tissue growth. Here, we describe a biomimetic, hyaluronic acid (HA)-based hydrogel platform containing covalently immobilized bioactive peptides derived from perlecan domain IV (TWSKV), laminin-111 (YIGSR, IKVAV), and fibronectin (RGDSP). The HA network was established by the thiol/acrylate reaction, and bioactive peptides were conjugated to the network with high efficiency without significantly altering the mechanical property of the matrix. When encapsulated as single cells in peptide-modified HA hydrogels, human salivary gland stem/progenitor cells (hS/PCs) spontaneously organized into multicellular spheroids with close cell–cell contacts. Conjugation of RGDSP and TWSKV signals in HA gels significantly accelerated cell proliferation, with the largest spheroids observed in RGDSP-tagged gels. Peptide conjugation did not significantly alter the expression of acinar (AMY1), ductal (TFCP2L1), and progenitor (KRT14) markers at the mRNA level. Characterization of three-dimensional (3D) cultures by immunocytochemistry showed positive staining for keratin-5 (K5), keratin-14 (K14), integrin-β1, and α-amylase under all culture conditions, confirming the maintenance of the secretory progenitor cell population. Two-dimensional (2D) adhesion studies revealed that integrin-β1 played a key role in facilitating cell–matrix interaction in gels with RGDSP, IKVAV, and TWSKV signals. Overall, conjugation of the RGDSP peptide to HA gels improved cell viability, accelerated the formation of epithelial spheroids, and promoted the expansion of the progenitor cell population in 3D. This work represents an essential first step toward the development of an engineered salivary gland.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Department of Materials Science and Engineering, University of Delaware, 210 South College Avenue, Newark, Delaware 19716, United States
Department of Otolaryngology−Head & Neck Surgery, Thomas Jefferson University, 1020 Walnut Street, Philadelphia, Pennsylvania 19107, United States
Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, 4701 Ogletown Stanton Road, Newark, Delaware 19713, United States
Department of Biomedical Engineering, University of Delaware, 210 South College Avenue, Newark, Delaware 19716, United States
Delaware Biotechnology Institute, 590 Avenue 1743, Newark, Delaware 19711, United States
Funding
National Institute on Deafness and Other Communication Disorders · National Institute of Dental and Craniofacial Research · University of Delaware · Division of Materials Research · Delaware Bioscience Center for Advanced Technology